Aprocitentan
In Stock•Starting at $61 for 1 mg•Purity ≥ 98%
| CAS No. | 1103522-45-7 |
|---|---|
| MDL No. | MFCD28155267 |
| MF | C16H14Br2N6O4S |
| MW | 546.20 |
| InChI Key | DKULOVKANLVDEA-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 98% | $61 | In Stock | |
| 5 mg | 98% | $150 | In Stock | |
| 10 mg | 98% | $181 | In Stock | |
| 25 mg | 98% | $215 | In Stock | |
| 50 mg | 98% | $427 | In Stock |
Product Information
ACT-132577 is a sulfamide with one amino group substituted by a 5-(4-bromophenyl)-6-{2-[(5-bromopyrimidin-2-yl)oxy]ethoxy}pyrimidin-4-yl group. It is an active metabolite of macitentan, an orphan drug for pulmonary arterial hypertension. It functions as an antihypertensive, endothelin receptor antagonist, drug metabolite, and xenobiotic metabolite. It is an aromatic ether, organobromine compound, pyrimidine, sulfamide, and functionally related to ethylene glycol.
| CAS No. | 1103522-45-7 |
|---|---|
| Product Name | Aprocitentan |
Biological Targets
EDNRB·EDNRA
Associated Conditions
hypertension·liver disease·kidney disease·essential hypertension
* The information provided here is compiled from public sources and is for reference only.
